Who Is Eligible for Semaglutide (GLP-1) in India? Complete Eligibility Guide

By GLP1Score Team | Published 2026-04-02 | 12 min read

Generic semaglutide now costs as little as ₹1,290 per month in India. Millions of people are asking the same question: "Can I take it?"

The honest answer: it depends. Semaglutide is a prescription medication with specific eligibility criteria. Not everyone qualifies. And some people should absolutely not take it.

This guide explains exactly who is eligible, who isn't, and how to find out where you stand — based on DCGI guidelines, international obesity medicine standards, and South Asian-specific research.

The Basic Eligibility Criteria

Semaglutide for weight management (Wegovy and generics at 2.4mg dose) is approved for adults who meet one of these criteria:

BMI 30 or above (obese) — regardless of other conditions
BMI 27 or above with at least one weight-related health condition — Type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea, or cardiovascular disease

For Type 2 diabetes management (Ozempic and generics at 0.5–1mg dose), the criteria are broader. If you have T2DM and your blood sugar isn't well controlled with metformin alone, semaglutide can be added as a second-line treatment.

But wait — those BMI numbers are based on Western populations. For South Asians, the thresholds should be lower. More on this in the South Asian BMI section below.

If You Have Type 2 Diabetes

This is semaglutide's primary approved use. Ozempic was designed as a diabetes drug first, weight loss drug second.

If you have Type 2 diabetes and your HbA1c is above 7% despite metformin, semaglutide is a strong option. It reduces HbA1c by 1.5–2.0% on average. It also promotes weight loss — a bonus that most diabetes drugs don't offer (many cause weight gain).

Even if your BMI is in the "normal" range (which is unlikely for most T2DM patients), you can still qualify. Your doctor will prescribe it based on diabetes control needs, not weight loss.

Ozempic (and its generics) is approved for diabetes at doses of 0.5mg and 1mg weekly. Wegovy (2.4mg) is the weight management dose. Your doctor picks the right indication and dose.

Conditions That Make You a STRONGER Candidate

The more weight-related conditions you have, the stronger the medical case for semaglutide. Here's the list that doctors look at:

Type 2 diabetes — The primary indication. Strongest case.
Prediabetes (HbA1c 5.7–6.4%) — Semaglutide can prevent progression to diabetes. Strong case.
Hypertension (high blood pressure) — Semaglutide reduces blood pressure by 3–5 mmHg in trials.
Dyslipidemia (high cholesterol/triglycerides) — Improves lipid profile in most patients.
PCOS (Polycystic Ovary Syndrome) — Weight loss with semaglutide improves hormonal balance and fertility in PCOS patients. Increasingly prescribed by gynecologists.
Non-alcoholic fatty liver disease (NAFLD/NASH) — Semaglutide reduces liver fat. A 2021 NEJM study showed NASH resolution in 59% of semaglutide patients vs 17% on placebo.
Obstructive sleep apnea — Weight loss reduces severity of sleep apnea episodes.
Cardiovascular disease history — The SELECT trial (17,604 participants) showed semaglutide reduced major cardiovascular events by 20% in overweight/obese patients with existing heart disease. This is a strong indication.
Osteoarthritis / joint problems from weight — Weight loss reduces joint stress. Doctors increasingly prescribe semaglutide to knee/hip arthritis patients.

If you have 2–3 conditions from this list along with a BMI of 27+, most endocrinologists will consider you a good candidate.

Who Should NOT Take Semaglutide (Contraindications)

Absolute contraindications (never take semaglutide if you have these):

Personal or family history of medullary thyroid carcinoma (MTC) — Semaglutide caused thyroid C-cell tumors in rodent studies. If you or a first-degree relative had MTC, this drug is off-limits.
Multiple Endocrine Neoplasia type 2 (MEN2) syndrome — A genetic condition linked to MTC risk.
Pregnancy or planning pregnancy — Semaglutide must be stopped at least 2 months before trying to conceive. It can harm fetal development.
Type 1 diabetes — Semaglutide is NOT for T1DM. It doesn't replace insulin. Using it in T1DM can cause dangerous ketoacidosis.
Known allergy to semaglutide — Rare but possible. If you had a reaction to Ozempic/Wegovy/liraglutide before, do not take it again.

Relative contraindications (may still be prescribed with caution):

History of pancreatitis — Semaglutide may increase pancreatitis risk. Your doctor will weigh benefits vs risks.
Active eating disorders (anorexia, bulimia) — A drug that suppresses appetite can worsen eating disorders. Needs psychiatric evaluation first.
Severe kidney disease (eGFR below 15) — Limited safety data. Dose adjustment and monitoring needed.
Gastroparesis (delayed stomach emptying) — Semaglutide further slows gastric emptying. Can worsen symptoms significantly.
Breastfeeding — Unknown if semaglutide passes into breast milk. Most doctors advise against it.
Diabetic retinopathy (active) — Rapid blood sugar improvement can temporarily worsen retinopathy. Get an eye checkup first.

If any of these apply to you, it doesn't automatically disqualify you. It means your doctor needs to make a careful risk-benefit assessment.

Want to know where you stand? Take our free eligibility assessment. We screen for all eligibility criteria, contraindications, and risk factors across 6 medical dimensions — and give you a personalized score.

Check My GLP-1 Eligibility — Free

The South Asian BMI Problem

Standard BMI cutoffs were developed studying European populations. They don't work well for South Asians. This is well-established science, not opinion.

The WHO and ICMR both recognize that South Asians develop metabolic complications at lower BMI values. An Indian person with BMI 23 has the same metabolic risk (diabetes, heart disease) as a European person with BMI 25–27.

Here are the adjusted cutoffs for South Asians:

Normal weight: BMI 18.5–22.9 (not 24.9)
Overweight: BMI 23–24.9 (not 25–29.9)
Obese: BMI 25+ (not 30+)

The ICMR-INDIAB study (the largest diabetes study in India, covering 113,043 people across all states) confirmed that diabetes prevalence doubles at BMI 23 for Indians compared to BMI 25 for Caucasians.

What this means for semaglutide eligibility: Many Indian doctors now use the South Asian cutoffs when evaluating patients. If your BMI is 25+ with comorbidities, you may qualify — even though Western guidelines would say you need 27+. This is especially relevant for PCOS patients and prediabetic patients who sit in the BMI 23–27 range.

Not all doctors follow South Asian cutoffs yet. If your doctor uses Western BMI thresholds and you have conditions like diabetes, PCOS, or fatty liver, ask them about the adjusted criteria.

What Your Doctor Actually Looks At

When you visit an endocrinologist for GLP-1 evaluation, here's what happens:

BMI calculation — They'll measure your height and weight. They may also measure waist circumference (abdominal obesity is an independent risk factor for Indians).
Blood test review — HbA1c, fasting glucose, lipid panel, liver function, kidney function, thyroid. If you bring these from a lab, it saves time and money.
Medical history — Every condition from the "stronger candidate" list. Family history of thyroid cancer (critical). History of pancreatitis, gallstones, eating disorders.
Current medications — Drug interactions check. Insulin users may need dose reduction. Oral contraceptive timing may need adjustment.
Prior weight loss attempts — Most doctors want to know what you've tried before. Diet, exercise, other medications (orlistat, phentermine). This isn't gatekeeping — it's assessing whether you're ready for the commitment.
Willingness to commit — Semaglutide works best with diet and exercise changes. If you expect the injection to do all the work, results will be modest. Doctors assess whether you'll follow the lifestyle plan alongside medication.

The evaluation takes 15–30 minutes. A good endocrinologist will explain why you do or don't qualify and discuss alternatives if semaglutide isn't right for you.

Common Myths About GLP-1 Eligibility

Myth 1: "I'm not diabetic so I can't take semaglutide."
Wrong. Wegovy (semaglutide 2.4mg) is specifically approved for weight management in non-diabetic patients with BMI 30+ or BMI 27+ with conditions. You don't need diabetes to qualify.

Myth 2: "My BMI is only 26, so I definitely don't qualify."
Wrong — especially for South Asians. With the adjusted BMI cutoffs, 26 with a comorbidity (PCOS, prediabetes, fatty liver) may well qualify. Ask your doctor.

Myth 3: "I need to try everything else first."
Not required if your BMI is 30+ or 27+ with conditions. Some doctors prefer that you've tried diet and exercise first, but there's no mandatory "failure first" rule. If your health situation warrants it, you can start directly.

Myth 4: "Semaglutide is only for women."
Wrong. It works equally well in men. Clinical trials included roughly equal men and women. Men often see faster early weight loss due to higher baseline calorie expenditure.

Myth 5: "Once you start, you have to take it forever."
Not necessarily. But honestly — weight tends to return when you stop. The STEP 1 extension trial showed that patients regained about two-thirds of lost weight within a year of stopping. Most doctors now recommend long-term use or a gradual taper with lifestyle maintenance. The duration is a conversation between you and your doctor.

Which Doctor to See for GLP-1 Prescription

Best options:

Endocrinologist — The gold standard. They specialize in hormones, diabetes, and metabolic disorders. Most experienced with GLP-1 dose escalation and managing side effects.
Diabetologist — If your primary concern is diabetes management. Many diabetologists now also handle obesity treatment.
Obesity medicine specialist — A growing speciality in India. They focus exclusively on medical weight management. Found at larger hospitals.

Avoid: General practitioners who aren't experienced with dose escalation. GLP-1 drugs require a specific escalation schedule and side effect monitoring that GPs may not be familiar with.

Where to find them: Apollo Hospitals, Max Healthcare, Fortis, Manipal, and Narayana Health all have obesity and endocrinology departments. AIIMS and government hospitals also have endocrinology departments (longer wait times but lower consultation fees).

Consultation cost: ₹500–1,500 in most metros. ₹300–800 in tier 2/3 cities. Some hospitals charge up to ₹2,000 for specialists. Government hospitals: ₹10–100.

If you're in a smaller city without a specialist, many endocrinologists now do teleconsultations through Practo, Apollo 24|7, or MFine. Cost: ₹300–800.

Tests to Get Before Your Appointment

Save time and money by getting these blood tests at a diagnostic lab before your first appointment. Your doctor will need them anyway.

HbA1c — ₹300–500
Fasting blood glucose — ₹80–150
Fasting lipid profile — ₹400–600
Liver function test (LFT) — ₹300–500
Kidney function test (KFT) — ₹400–600
Thyroid profile (TSH, T3, T4) — ₹500–800
Complete blood count (CBC) — ₹200–300
Vitamin B12 — ₹400–600

Total cost: ₹2,500–4,000 at labs like Thyrocare, SRL, Dr. Lal PathLabs, or Metropolis. Many offer home collection.

Pro tip: Search "obesity profile" or "metabolic health package" on Thyrocare or 1mg Labs. These bundled packages cover most of the above tests at 30–40% discount.

Our free assessment checks your eligibility across all these criteria in 5 minutes. Answer 30 questions and get your personalized eligibility score, red flags, brand recommendations, and a PDF report to take to your doctor.

Take the Free Assessment

Frequently Asked Questions

What BMI do I need for semaglutide in India?+

BMI 30+ (obese) or BMI 27+ with a weight-related condition like diabetes, hypertension, or PCOS. For South Asians, many doctors use lower cutoffs — BMI 25+ with conditions may qualify based on WHO South Asian guidelines.

Can I take semaglutide just for weight loss without diabetes?+

Yes. Wegovy (semaglutide 2.4mg) is approved specifically for weight management in people with BMI 30+ or BMI 27+ with at least one weight-related condition. Diabetes is not required.

Is there an age limit for semaglutide?+

Approved for adults 18 and older. There's no upper age limit, but doctors exercise extra caution in patients over 65 — especially regarding dehydration risk, muscle mass loss, and interactions with other medications.

Can I take semaglutide if I'm on metformin?+

Yes. Semaglutide + metformin is a standard and well-studied combination. In fact, metformin is often continued alongside semaglutide for diabetes patients. Your doctor may adjust the metformin dose if blood sugar drops too low.

How do I check if I'm eligible for GLP-1 therapy?+

Take the free GLP1Score assessment. It evaluates your BMI, health conditions, contraindications, medications, and readiness across 6 dimensions. You get a personalized eligibility score and a PDF report to share with your doctor.

Sources: WHO — Appropriate BMI for Asian Populations, NEJM — SELECT Trial (Semaglutide and Cardiovascular Outcomes), ICMR-INDIAB Study

Back to Blog | Compare Brands | Check Your Eligibility — Free